Back
Armata Pharmaceuticals Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
ARMP
Armata Pharmaceuticals
Last Price:
$1.45
Seasonality Move:
7.97%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
The current trend is relatively stagnant and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.41 | Sell |
| 20-day SMA: | 1.33 | Sell |
| 50-day SMA: | 1.56 | Sell |
| 200-day SMA: | 2.1 | Sell |
| 8-day EMA: | 1.38 | Sell |
| 20-day EMA: | 1.38 | Sell |
| 50-day EMA: | 1.52 | Sell |
| 200-day EMA: | 2.03 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 43.84 | Sell |
| Chaikin Money Flow: | -13302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 1.45) | Buy |
| Bollinger Bands (100): | (1.45 - 2.15) | Sell |
Armata Pharmaceuticals Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.29 while ARMP 8-day simple moving average is 1.41, which is a Sell signal.
-
The stock price of ARMP is 1.29 while Armata Pharmaceuticals 20-day SMA is 1.33, which makes it a Sell.
-
Armata Pharmaceuticals 50-day simple moving average is 1.56 while ARMP share price is 1.29, making it a Sell technically.
-
ARMP stock price is 1.29 and Armata Pharmaceuticals 200-day simple moving average is 2.10, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Sell
24
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a SellThe current Armata Pharmaceuticals [ARMP] share price is $1.29. The Score for ARMP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
46.7M
Price in USD:
1.29
Share Volume:
15.2K
Armata Pharmaceuticals 52-Week Range
52-Week High:
3.42
52-Week Low:
0.90
Sell
24
Armata Pharmaceuticals (ARMP)
is a Sell
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 1.29 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.29 while ARMP 8-day exponential moving average is 1.38, which is a Sell signal.
-
The stock price of ARMP is 1.29 while Armata Pharmaceuticals 20-day EMA is 1.38, which makes it a Sell.
-
Armata Pharmaceuticals 50-day exponential moving average is 1.52 while ARMP share price is 1.29, making it a Sell technically.
-
ARMP stock price is 1.29 and Armata Pharmaceuticals 200-day simple moving average is 2.03, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Armata Pharmaceuticals is a Sell
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 43.84, which suggest Armata Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (1.11 - 1.45), which suggest Armata Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (1.45 - 2.15), which suggest Armata Pharmaceuticals is a Sell
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.